Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

Updated: November 10, 2021

MedRhythms hires neuroscience expert to lead clinical trials

MedRhythms, a growing Portland-based digital health startup, on Wednesday announced a key hire to oversee all of its clinical trials — including a current one studying the company's solution for stroke patients.

Sabrina Taylor, who previously served as director of clinical studies for the Brain and Spinal Injury Center at the University of California San Francisco, based at Zuckerberg San Francisco General Hospital, recently relocated to Portland to join MedRhythms as head of clinical trials.

Sabrina Taylor headshot
Courtesy / MedRhythms
Sabrina Taylor, who recently served as director of clinical studies for the Brian and Spinal Injury Center at the University of California San Francisco, based at Zuckerberg San Francisco General Hospital, has been named head of clinical trials at MedRhythms, a Portland-based digital health startup.

Taylor, who holds a Ph.D. in experimental and molecular medicine from Dartmouth College and a bachelor of science degree in neuroscience from Stonehill College in Massachusetts, will oversee trials for MedRhythms’ pipeline products at institutions across the country.

"Sabrina has worked with some of the leading researchers in neurological rehabilitation and has a track record of excellence in all that she does," Brian Harris, co-founder and CEO of MedRhythms, told Mainebiz via email. "That, combined with her passion for positively impacting the lives of patients, made her a great addition to the team and someone who will elevate our organization."

Taylor said, “I am thrilled to be joining the MedRhythms team at this pivotal time as the company looks to advance evidence-based digital therapeutics to treat a range of neurologic injuries and diseases,” Taylor said in a news release. 

MedRthyms, whose co-founders were honored on the 2018 Mainebiz Next List, uses clinical sensors, software and music to restore function lost to neurological injury or disease. 

Taylor's appointment comes less than two months after MedRhythms unveiled a partnership with Universal Music Group to bring "prescription music" to patients.

Besides the ongoing clinical trial for the company's therapeutic for chronic stroke survivors with walking impairments, MedRhythms is conducting research for its pipeline products in other neurologic injuries and diseases, including Parkinson's disease, acute stroke and multiple sclerosis.

In July, MedRhythms raised $25 million in an oversubscribed Series B venture capital financing round.

The company currently employs 26 people full-time and is seeking to fill several open positions, according to Brittany Mailman, head of people and culture at MedRhythms.

Harris and fellow co-founder Owen McCarthy spoke of hiring plans in a recent "On the Record" Q&A with Mainebiz, saying, "We are looking across the country for top talent who are committed to the mission and to make a big impact in the world."

Sign up for Enews


Order a PDF